Karo Intressenter AB owns approximately 66.5 per cent of the outstanding shares in Karo Pharma Aktiebolag after the expiry of the final acceptance period

For more information, click here. 

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2021. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180